Inici › Leucèmia limfàtica crònica › Carolina del Nord › Durham
Assaigs clínics de Leucèmia limfàtica crònica a Durham, NC
27 estudis de Leucèmia limfàtica crònica busquen participants en centres de Durham i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
ReclutantFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
ReclutantFase 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi
- University of North Carolina-Hillsborough Campus, Hillsborough · a 13 mi
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
ReclutantFase 3
- University of North Carolina At Chapel Hill, Chapel Hill · a 10 mi
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
ReclutantFase 3
- Duke University Medical Center, Durham
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ReclutantFase 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · a 10 mi
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ReclutantFase 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ReclutantFase 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
ReclutantFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
ReclutantFase 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · a 10 mi
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutantFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · a 10 mi
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
ReclutantFase 2
- Research Site, Durham
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
ReclutantFase 1
- University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutantFase 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Reclutant
- North Carolina Basnight Cancer Hospital, Chapel Hill · a 10 mi
Registry of Older Patients With Cancer
ReclutantEstudi observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ReclutantFase 1
- University of North Carolina, Chapel Hill · a 10 mi
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
ReclutantFase 4
- Duke University Medical Center, Durham
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
ReclutantFase 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
ReclutantFase 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
ReclutantFase 2
- University of North Carolina /ID# 233313, Chapel Hill · a 10 mi
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
ReclutantFase 2
- The University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
ReclutantFase 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
ReclutantEstudi observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ReclutantFase 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
ReclutantFase 1
- University of North Carolina, Chapel Hill · a 10 mi
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
ReclutantFase 1
- Duke University, Durham
Assaigs de Leucèmia limfàtica crònica en altres ciutats
- Boston, MA31 estudis
- Columbus, OH28 estudis
- Washington, DC22 estudis
- Seattle, WA20 estudis
- Rochester, MN19 estudis
- New York City, NY18 estudis
- Houston, TX17 estudis
- Baldwin Park, CA16 estudis
- Milwaukee, WI15 estudis
- Cincinnati, OH14 estudis
- Chicago, IL14 estudis
- Nashville, TN13 estudis
Altres estudis a Durham
- Càncer de mama63 estudis
- Càncer (tots els tipus)58 estudis
- Càncer de pulmó de cèl·lules no petites39 estudis
- Mieloma múltiple37 estudis
- Càncer metastàtic33 estudis
- Leucèmia mieloide aguda33 estudis
- Càncer de pulmó32 estudis
- Càncer de pròstata32 estudis
- Càncer colorrectal28 estudis
- Càncer d'ovari27 estudis
- Insuficiència cardíaca26 estudis
- Càncer de pàncrees24 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.